Global Human Microbiome Market 2023 by Company, Regions, Type and Application, Forecast to 2029
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
According to our (Global Info Research) latest study, the global Human Microbiome market size was valued at USD 396 million in 2022 and is forecast to a readjusted size of USD 1483.8 million by 2029 with a CAGR of 20.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
This report is a detailed and comprehensive analysis for global Human Microbiome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Microbiome market size and forecasts, in consumption value ($ Million), 2018-2029
Global Human Microbiome market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Human Microbiome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Human Microbiome market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Microbiome
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Microbiome market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vedanta, Seres Therapeutics, Second Genome, Rebiotix and ActoGeniX, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Human Microbiome market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Market segment by Application
Treatment
Diagnosis
Market segment by players, this report covers
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Microbiome product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Microbiome, with revenue, gross margin and global market share of Human Microbiome from 2018 to 2023.
Chapter 3, the Human Microbiome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Human Microbiome market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Microbiome.
Chapter 13, to describe Human Microbiome research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Human Microbiome
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Microbiome by Type
1.3.1 Overview: Global Human Microbiome Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Human Microbiome Consumption Value Market Share by Type in 2022
1.3.3 Gastrointestinal Tract Human Micobiome
1.3.4 Urogenital Tract Human Micobiome
1.3.5 Others
1.4 Global Human Microbiome Market by Application
1.4.1 Overview: Global Human Microbiome Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Treatment
1.4.3 Diagnosis
1.5 Global Human Microbiome Market Size & Forecast
1.6 Global Human Microbiome Market Size and Forecast by Region
1.6.1 Global Human Microbiome Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Human Microbiome Market Size by Region, (2018-2029)
1.6.3 North America Human Microbiome Market Size and Prospect (2018-2029)
1.6.4 Europe Human Microbiome Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Human Microbiome Market Size and Prospect (2018-2029)
1.6.6 South America Human Microbiome Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Human Microbiome Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Vedanta
2.1.1 Vedanta Details
2.1.2 Vedanta Major Business
2.1.3 Vedanta Human Microbiome Product and Solutions
2.1.4 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Vedanta Recent Developments and Future Plans
2.2 Seres Therapeutics
2.2.1 Seres Therapeutics Details
2.2.2 Seres Therapeutics Major Business
2.2.3 Seres Therapeutics Human Microbiome Product and Solutions
2.2.4 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Seres Therapeutics Recent Developments and Future Plans
2.3 Second Genome
2.3.1 Second Genome Details
2.3.2 Second Genome Major Business
2.3.3 Second Genome Human Microbiome Product and Solutions
2.3.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Second Genome Recent Developments and Future Plans
2.4 Rebiotix
2.4.1 Rebiotix Details
2.4.2 Rebiotix Major Business
2.4.3 Rebiotix Human Microbiome Product and Solutions
2.4.4 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rebiotix Recent Developments and Future Plans
2.5 ActoGeniX
2.5.1 ActoGeniX Details
2.5.2 ActoGeniX Major Business
2.5.3 ActoGeniX Human Microbiome Product and Solutions
2.5.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 ActoGeniX Recent Developments and Future Plans
2.6 Enterome BioScience
2.6.1 Enterome BioScience Details
2.6.2 Enterome BioScience Major Business
2.6.3 Enterome BioScience Human Microbiome Product and Solutions
2.6.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Enterome BioScience Recent Developments and Future Plans
2.7 AvidBiotics
2.7.1 AvidBiotics Details
2.7.2 AvidBiotics Major Business
2.7.3 AvidBiotics Human Microbiome Product and Solutions
2.7.4 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AvidBiotics Recent Developments and Future Plans
2.8 4D Pharma Research Ltd
2.8.1 4D Pharma Research Ltd Details
2.8.2 4D Pharma Research Ltd Major Business
2.8.3 4D Pharma Research Ltd Human Microbiome Product and Solutions
2.8.4 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 4D Pharma Research Ltd Recent Developments and Future Plans
2.9 Enterologics
2.9.1 Enterologics Details
2.9.2 Enterologics Major Business
2.9.3 Enterologics Human Microbiome Product and Solutions
2.9.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Enterologics Recent Developments and Future Plans
2.10 Metabogen
2.10.1 Metabogen Details
2.10.2 Metabogen Major Business
2.10.3 Metabogen Human Microbiome Product and Solutions
2.10.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Metabogen Recent Developments and Future Plans
2.11 Metabiomics
2.11.1 Metabiomics Details
2.11.2 Metabiomics Major Business
2.11.3 Metabiomics Human Microbiome Product and Solutions
2.11.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Metabiomics Recent Developments and Future Plans
2.12 Ritter Pharmaceuticals
2.12.1 Ritter Pharmaceuticals Details
2.12.2 Ritter Pharmaceuticals Major Business
2.12.3 Ritter Pharmaceuticals Human Microbiome Product and Solutions
2.12.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Ritter Pharmaceuticals Recent Developments and Future Plans
2.13 Osel
2.13.1 Osel Details
2.13.2 Osel Major Business
2.13.3 Osel Human Microbiome Product and Solutions
2.13.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Osel Recent Developments and Future Plans
2.14 Symberix
2.14.1 Symberix Details
2.14.2 Symberix Major Business
2.14.3 Symberix Human Microbiome Product and Solutions
2.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Symberix Recent Developments and Future Plans
2.15 Miomics
2.15.1 Miomics Details
2.15.2 Miomics Major Business
2.15.3 Miomics Human Microbiome Product and Solutions
2.15.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Miomics Recent Developments and Future Plans
2.16 Symbiotix Biotherapies
2.16.1 Symbiotix Biotherapies Details
2.16.2 Symbiotix Biotherapies Major Business
2.16.3 Symbiotix Biotherapies Human Microbiome Product and Solutions
2.16.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Symbiotix Biotherapies Recent Developments and Future Plans
2.17 MicroBiome Therapeutics LLC
2.17.1 MicroBiome Therapeutics LLC Details
2.17.2 MicroBiome Therapeutics LLC Major Business
2.17.3 MicroBiome Therapeutics LLC Human Microbiome Product and Solutions
2.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Human Microbiome Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Human Microbiome by Company Revenue
3.2.2 Top 3 Human Microbiome Players Market Share in 2022
3.2.3 Top 6 Human Microbiome Players Market Share in 2022
3.3 Human Microbiome Market: Overall Company Footprint Analysis
3.3.1 Human Microbiome Market: Region Footprint
3.3.2 Human Microbiome Market: Company Product Type Footprint
3.3.3 Human Microbiome Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Human Microbiome Consumption Value and Market Share by Type (2018-2023)
4.2 Global Human Microbiome Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Human Microbiome Consumption Value Market Share by Application (2018-2023)
5.2 Global Human Microbiome Market Forecast by Application (2024-2029)
6 North America
6.1 North America Human Microbiome Consumption Value by Type (2018-2029)
6.2 North America Human Microbiome Consumption Value by Application (2018-2029)
6.3 North America Human Microbiome Market Size by Country
6.3.1 North America Human Microbiome Consumption Value by Country (2018-2029)
6.3.2 United States Human Microbiome Market Size and Forecast (2018-2029)
6.3.3 Canada Human Microbiome Market Size and Forecast (2018-2029)
6.3.4 Mexico Human Microbiome Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Human Microbiome Consumption Value by Type (2018-2029)
7.2 Europe Human Microbiome Consumption Value by Application (2018-2029)
7.3 Europe Human Microbiome Market Size by Country
7.3.1 Europe Human Microbiome Consumption Value by Country (2018-2029)
7.3.2 Germany Human Microbiome Market Size and Forecast (2018-2029)
7.3.3 France Human Microbiome Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Human Microbiome Market Size and Forecast (2018-2029)
7.3.5 Russia Human Microbiome Market Size and Forecast (2018-2029)
7.3.6 Italy Human Microbiome Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Human Microbiome Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Human Microbiome Market Size by Region
8.3.1 Asia-Pacific Human Microbiome Consumption Value by Region (2018-2029)
8.3.2 China Human Microbiome Market Size and Forecast (2018-2029)
8.3.3 Japan Human Microbiome Market Size and Forecast (2018-2029)
8.3.4 South Korea Human Microbiome Market Size and Forecast (2018-2029)
8.3.5 India Human Microbiome Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Human Microbiome Market Size and Forecast (2018-2029)
8.3.7 Australia Human Microbiome Market Size and Forecast (2018-2029)
9 South America
9.1 South America Human Microbiome Consumption Value by Type (2018-2029)
9.2 South America Human Microbiome Consumption Value by Application (2018-2029)
9.3 South America Human Microbiome Market Size by Country
9.3.1 South America Human Microbiome Consumption Value by Country (2018-2029)
9.3.2 Brazil Human Microbiome Market Size and Forecast (2018-2029)
9.3.3 Argentina Human Microbiome Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Human Microbiome Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Human Microbiome Market Size by Country
10.3.1 Middle East & Africa Human Microbiome Consumption Value by Country (2018-2029)
10.3.2 Turkey Human Microbiome Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Human Microbiome Market Size and Forecast (2018-2029)
10.3.4 UAE Human Microbiome Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Human Microbiome Market Drivers
11.2 Human Microbiome Market Restraints
11.3 Human Microbiome Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Human Microbiome Industry Chain
12.2 Human Microbiome Upstream Analysis
12.3 Human Microbiome Midstream Analysis
12.4 Human Microbiome Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Tables and Figures
List of Tables
Table 1. Global Human Microbiome Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Microbiome Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Human Microbiome Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Human Microbiome Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Vedanta Company Information, Head Office, and Major Competitors
Table 6. Vedanta Major Business
Table 7. Vedanta Human Microbiome Product and Solutions
Table 8. Vedanta Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Vedanta Recent Developments and Future Plans
Table 10. Seres Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Seres Therapeutics Major Business
Table 12. Seres Therapeutics Human Microbiome Product and Solutions
Table 13. Seres Therapeutics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Seres Therapeutics Recent Developments and Future Plans
Table 15. Second Genome Company Information, Head Office, and Major Competitors
Table 16. Second Genome Major Business
Table 17. Second Genome Human Microbiome Product and Solutions
Table 18. Second Genome Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Second Genome Recent Developments and Future Plans
Table 20. Rebiotix Company Information, Head Office, and Major Competitors
Table 21. Rebiotix Major Business
Table 22. Rebiotix Human Microbiome Product and Solutions
Table 23. Rebiotix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Rebiotix Recent Developments and Future Plans
Table 25. ActoGeniX Company Information, Head Office, and Major Competitors
Table 26. ActoGeniX Major Business
Table 27. ActoGeniX Human Microbiome Product and Solutions
Table 28. ActoGeniX Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. ActoGeniX Recent Developments and Future Plans
Table 30. Enterome BioScience Company Information, Head Office, and Major Competitors
Table 31. Enterome BioScience Major Business
Table 32. Enterome BioScience Human Microbiome Product and Solutions
Table 33. Enterome BioScience Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Enterome BioScience Recent Developments and Future Plans
Table 35. AvidBiotics Company Information, Head Office, and Major Competitors
Table 36. AvidBiotics Major Business
Table 37. AvidBiotics Human Microbiome Product and Solutions
Table 38. AvidBiotics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. AvidBiotics Recent Developments and Future Plans
Table 40. 4D Pharma Research Ltd Company Information, Head Office, and Major Competitors
Table 41. 4D Pharma Research Ltd Major Business
Table 42. 4D Pharma Research Ltd Human Microbiome Product and Solutions
Table 43. 4D Pharma Research Ltd Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. 4D Pharma Research Ltd Recent Developments and Future Plans
Table 45. Enterologics Company Information, Head Office, and Major Competitors
Table 46. Enterologics Major Business
Table 47. Enterologics Human Microbiome Product and Solutions
Table 48. Enterologics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Enterologics Recent Developments and Future Plans
Table 50. Metabogen Company Information, Head Office, and Major Competitors
Table 51. Metabogen Major Business
Table 52. Metabogen Human Microbiome Product and Solutions
Table 53. Metabogen Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Metabogen Recent Developments and Future Plans
Table 55. Metabiomics Company Information, Head Office, and Major Competitors
Table 56. Metabiomics Major Business
Table 57. Metabiomics Human Microbiome Product and Solutions
Table 58. Metabiomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Metabiomics Recent Developments and Future Plans
Table 60. Ritter Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Ritter Pharmaceuticals Major Business
Table 62. Ritter Pharmaceuticals Human Microbiome Product and Solutions
Table 63. Ritter Pharmaceuticals Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Ritter Pharmaceuticals Recent Developments and Future Plans
Table 65. Osel Company Information, Head Office, and Major Competitors
Table 66. Osel Major Business
Table 67. Osel Human Microbiome Product and Solutions
Table 68. Osel Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Osel Recent Developments and Future Plans
Table 70. Symberix Company Information, Head Office, and Major Competitors
Table 71. Symberix Major Business
Table 72. Symberix Human Microbiome Product and Solutions
Table 73. Symberix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Symberix Recent Developments and Future Plans
Table 75. Miomics Company Information, Head Office, and Major Competitors
Table 76. Miomics Major Business
Table 77. Miomics Human Microbiome Product and Solutions
Table 78. Miomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Miomics Recent Developments and Future Plans
Table 80. Symbiotix Biotherapies Company Information, Head Office, and Major Competitors
Table 81. Symbiotix Biotherapies Major Business
Table 82. Symbiotix Biotherapies Human Microbiome Product and Solutions
Table 83. Symbiotix Biotherapies Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Symbiotix Biotherapies Recent Developments and Future Plans
Table 85. MicroBiome Therapeutics LLC Company Information, Head Office, and Major Competitors
Table 86. MicroBiome Therapeutics LLC Major Business
Table 87. MicroBiome Therapeutics LLC Human Microbiome Product and Solutions
Table 88. MicroBiome Therapeutics LLC Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. MicroBiome Therapeutics LLC Recent Developments and Future Plans
Table 90. Global Human Microbiome Revenue (USD Million) by Players (2018-2023)
Table 91. Global Human Microbiome Revenue Share by Players (2018-2023)
Table 92. Breakdown of Human Microbiome by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Human Microbiome, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Human Microbiome Players
Table 95. Human Microbiome Market: Company Product Type Footprint
Table 96. Human Microbiome Market: Company Product Application Footprint
Table 97. Human Microbiome New Market Entrants and Barriers to Market Entry
Table 98. Human Microbiome Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Human Microbiome Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Human Microbiome Consumption Value Share by Type (2018-2023)
Table 101. Global Human Microbiome Consumption Value Forecast by Type (2024-2029)
Table 102. Global Human Microbiome Consumption Value by Application (2018-2023)
Table 103. Global Human Microbiome Consumption Value Forecast by Application (2024-2029)
Table 104. North America Human Microbiome Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Human Microbiome Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Human Microbiome Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Human Microbiome Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Human Microbiome Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Human Microbiome Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Human Microbiome Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Human Microbiome Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Human Microbiome Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Human Microbiome Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Human Microbiome Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Human Microbiome Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Human Microbiome Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Human Microbiome Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Human Microbiome Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Human Microbiome Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Human Microbiome Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Human Microbiome Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Human Microbiome Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Human Microbiome Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Human Microbiome Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Human Microbiome Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Human Microbiome Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Human Microbiome Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Human Microbiome Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Human Microbiome Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Human Microbiome Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Human Microbiome Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Human Microbiome Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Human Microbiome Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Human Microbiome Raw Material
Table 135. Key Suppliers of Human Microbiome Raw Materials
List of Figures
Figure 1. Human Microbiome Picture
Figure 2. Global Human Microbiome Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Microbiome Consumption Value Market Share by Type in 2022
Figure 4. Gastrointestinal Tract Human Micobiome
Figure 5. Urogenital Tract Human Micobiome
Figure 6. Others
Figure 7. Global Human Microbiome Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Human Microbiome Consumption Value Market Share by Application in 2022
Figure 9. Treatment Picture
Figure 10. Diagnosis Picture
Figure 11. Global Human Microbiome Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Human Microbiome Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Human Microbiome Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Human Microbiome Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Human Microbiome Consumption Value Market Share by Region in 2022
Figure 16. North America Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Human Microbiome Revenue Share by Players in 2022
Figure 22. Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Human Microbiome Market Share in 2022
Figure 24. Global Top 6 Players Human Microbiome Market Share in 2022
Figure 25. Global Human Microbiome Consumption Value Share by Type (2018-2023)
Figure 26. Global Human Microbiome Market Share Forecast by Type (2024-2029)
Figure 27. Global Human Microbiome Consumption Value Share by Application (2018-2023)
Figure 28. Global Human Microbiome Market Share Forecast by Application (2024-2029)
Figure 29. North America Human Microbiome Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Human Microbiome Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Human Microbiome Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Human Microbiome Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Human Microbiome Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Human Microbiome Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 39. France Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Human Microbiome Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Human Microbiome Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Human Microbiome Consumption Value Market Share by Region (2018-2029)
Figure 46. China Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 49. India Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Human Microbiome Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Human Microbiome Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Human Microbiome Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Human Microbiome Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Human Microbiome Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Human Microbiome Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Human Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 63. Human Microbiome Market Drivers
Figure 64. Human Microbiome Market Restraints
Figure 65. Human Microbiome Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Human Microbiome in 2022
Figure 68. Manufacturing Process Analysis of Human Microbiome
Figure 69. Human Microbiome Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets